Список литературы

1. Воробьев А.И., editor. Руководство по гематологии: в 3 т. М.: "Ниюдиамед"; 2005.

2. Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: Results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10: 615 - 21. https://doi.org/10.1111/j.1538-7836.2012.04653.x.

3. Acharya SS, Coughlin A, Dimichele DM, Jublirer SJ, Arden D, Anderson V, et al. Rare bleeding disorder registry: Deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248 - 56. https://doi.org/10.1111/j.1538-7836.2003.t01-1-00553.x.

4. Herrmann FH, Auerswald G, Ruiz-Saez A, Navarrete M, Pollmann H, Lopaciuk S, et al. Factor X deficiency: Clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia 2006; 12: 479 - 89. https://doi.org/10.1111/j.1365-2516.2006.01303.x.

5. Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, et al. Factor VII deficiency: Clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009; 15: 267 - 80. https://doi.org/10.1111/j.1365-2516.2008.01910.x.

6. Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RAS, et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97: 914 - 21.

7. BERNARDI F, DOLCE A, PINOTTI M, SHAPIRO AD, SANTAGOSTINO E, PEYVANDI F, et al. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B. J Thromb Haemost 2009; 7: 774 - 9. https://doi.org/10.1111/j.1538-7836.2009.03329.x.

8. Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al. Guideline for the diagnosis and management of the rare coagulation disorders: A United Kingdom haemophilia centre doctors' organization guideline on behalf of the British committee for standards in haematology. Br J Haematol 2014; 167: 304 - 26.

9. Peyvandi F, Di Michele D, Bolton-Maggs PHB, Lee CA, Tripodi A, Srivastava A. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012; 10: 1938 - 43. https://doi.org/10.1111/j.1538-7836.2012.04844.x.

10. Баркаган З.С., Момот А.П. Диагностика и контролируемая терапия нарушений гемостаза. 2001.

11. Давыдкин И.Л., Момот А.П., Зозуля Н.И., Ройтман Е.В., editors. Основы клинической гемостазиологии и гемореологии: монография. Самара: ООО ИПК "Самарская Губерния"; 2017.

12. Akhavan S, Mannucci PM, Lak M, Mancuso G, Mazzucconi MG, Rocino A, et al. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency. Thromb Haemost 2000; 84: 989 - 97. https://doi.org/10.1055/s-0037-1614161.

13. Bolton-Maggs PHB, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disorders - Review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 593 - 628. https://doi.org/10.1111/j.1365-2516.2004.00944.x.

14. GIROLAMI A, VETTORE S, SCARPARO P, LOMBARDI AM. Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era. Haemophilia 2011; 17: 17 - 20. https://doi.org/10.1111/j.1365-2516.2010.02328.x.

15. KARIMI M, VAFAFAR A, HAGHPANAH S, PAYANDEH M, ESHGHI P, HOOFAR H, et al. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. Haemophilia 2012; 18: 211 - 5. https://doi.org/10.1111/j.1365-2516.2011.02635.x.

16. Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481 - 7. https://doi.org/10.1160/TH04-10-0650.

17. Момот А.П. Принципы и алгоритмы клинико-лабораторной диагностики. СПб: ФормаТ; 2006.

18. Добровольский А.Б., Косырев А.Б.. Протромбиновый тест: Методика выполнения и клиническое значение. Ассоциация Медицинской Лабораторной Диагностики Информационный Бюллетень 1995; 2: 34 - 8.

19. BROWN DL, KOUIDES PA. Diagnosis and treatment of inherited factor X deficiency. Haemophilia 2008; 14: 1176 - 82. https://doi.org/10.1111/j.1365-2516.2008.01856.x.

20. Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: An update. Semin Thromb Hemost 2013; 39: 596 - 606. https://doi.org/10.1055/s-0033-1348948.

21. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243 - 52. https://doi.org/10.1182/blood-2004-02-0595.

22. Di Minno MND, Dolce A, Mariani G. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb Haemost 2013; 109: 1051 - 9. https://doi.org/10.1160/TH12-10-0740.

23. Giansily-Blaizot M, Marty S, Chen SWW, Pellequer JL, Schved JF. Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous? Thromb Res 2012; 130. https://doi.org/10.1016/j.thromres.2012.08.273.

24. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2008; 14: 671 - 84. https://doi.org/10.1111/j.1365-2516.2008.01695.x.

25. Girolami A, Vettore S, Ruzzon E, Marinis GB De, Fabris F. Rare and unusual bleeding manifestations in congenital bleeding disorders: An annotated review. Clin Appl Thromb 2012; 18: 121 - 7. https://doi.org/10.1177/1076029611416638.

26. Ушакова О.Е., Нечипуренко Д.Ю., Бутылин А.А., Пантелеев М.А.. Применение проточных систем в лабораторной диагностике для интегральной оценки системы гемостаза. Вопросы Гематологии / Онкологии и Иммунопатологии в Педиатрии 2018; 17: 117 - 29.

27. Franchini M, Lippi G. Prothrombin complex concentrates: An update. Blood Transfus 2010; 8: 149 - 54. https://doi.org/10.2450/2010.0149-09.

28. Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood 2019; 133: 415 - 24. https://doi.org/10.1182/blood-2018-06-820738.

29. Dorgalaleh A, Tabibian S, Hosseini MS, Shams M. Pharmacological management of rare coagulation factor deficiencies besides hemophilia. Expert Rev Hematol 2020; 13. https://doi.org/10.1080/17474086.2020.1796622.

30. Peyvandi F, Menegatti M. Treatment of rare factor deficiencies in 2016. Hematol Am Soc Hematol Educ Progr 2016; 2016: 663 - 9. https://doi.org/10.1182/ASHEDUCATION-2016.1.663.

31. TODD T, J PERRY D. A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies. Haemophilia 2009; 16: 569 - 83. https://doi.org/10.1111/j.1365-2516.2009.02118.x.

32. Tengborn L, Blomback M, Berntorp E. Tranexamic acid - An old drug still going strong and making a revival. Thromb Res 2015; 135: 231 - 42. https://doi.org/10.1016/j.thromres.2014.11.012.

33. Berrettini M, Mariani G, Schiavoni M, Rocino A, Paolantonio T Di, Longo G, et al. Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency. vol. 86. 2001. https://doi.org/10.3324/%X.

34. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: Therapy with recombinant activated factor VII - A critical appraisal. Haemophilia 2006; 12: 19 - 27. https://doi.org/10.1111/j.1365-2516.2006.01180.x.

35. Mariani G, Dolce A, Batorova A, Auerswald G, Schved JF, Siragusa S, et al. Recombinant, activated factor VII for surgery in factor VII deficiency: A prospective evaluation - the surgical STER. Br J Haematol 2011; 152: 340 - 6. https://doi.org/10.1111/j.1365-2141.2010.08287.x.

36. Mariani G, Napolitano M, Dolce A, Garrido RP, Batorova A, Karimi M, et al. Replacement therapy for bleeding episodes in factor VII deficiency. Thromb Haemost 2013; 109: 238 - 47. https://doi.org/10.1160/TH12-07-0476.

37. Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, et al. Prophylaxis in congenital factor VII deficiency: Indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica 2013; 98: 538 - 44. https://doi.org/10.3324/haematol.2012.074039.

38. Mariani G, Dolce A, Marchetti G, Bernardi F. Clinical picture and management of congenital factor VII deficiency. Haemophilia 2004; 10 Suppl 4: 180 - 3. https://doi.org/10.1111/J.1365-2516.2004.00990.X.

39. Salcioglu Z, Akcay A, Sen HS, Aydogan G, Akici F, Tugcu D, et al. Factor VII deficiency: a single-center experience. Clin Appl Thromb Hemost 2012; 18: 588 - 93. https://doi.org/10.1177/1076029611435091.

40. McMahon C, Smith J, Goonan C, Byrne M, Smith OP. The role of primary prophylactic factor replacement therapy in children with severe factor X deficiency. Br J Haematol 2002; 119: 789 - 91. https://doi.org/10.1046/j.1365-2141.2002.03932.x.

41. Суворова А.В., Абраменко Л.И., Курденко И.В., Назарова Р.В. Патология системы гемостаза у новорожденных. Барнаул: 2004.

42. Шабалов Н.П. Гемостаз в динамике первой недели жизни как отражение механизмов адаптации к внеутробной жизни новорожденных. Педиатрия 2000; 3: 84 - 91.

43. BOWLES L, BAKER K, KHAIR K, MATHIAS M, LIESNER R. Prophylaxis with prothrombin complex concentrate in four children with severe congenital factor X deficiency. Haemophilia 2009; 15: 401 - 3. https://doi.org/10.1111/j.1365-2516.2008.01878.x.

44. Barillari G, Pasca S, Gonano N, Daminato R. Prothrombin complex concentrate such as therapy and prophylaxis in factor X-deficient patient (Friuli Variant). Clin Appl Thromb 2011; 17: 332 - 6. https://doi.org/10.1177/1076029610365331.

45. Kouides PA, Kulzer L. Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate. Haemophilia 2001; 7: 220 - 3. https://doi.org/10.1046/j.1365-2516.2001.00485.x.

46. Uprichard J, Perry DJ. Factor X deficiency. Blood Rev 2002; 16: 97 - 110. https://doi.org/10.1054/blre.2002.0191.

47. Van Veen JJ, Hampton KK, Maclean R, Fairlie F, Makris M. Blood product support for delivery in severe factor X deficiency: The use of thrombin generation to guide therapy. Blood Transfus 2007; 5: 204 - 9. https://doi.org/10.2450/2007.0023-07.

48. Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, et al. Correlating clinical manifestations with factor levels in rare bleeding disorders: A report from Southern India. Haemophilia 2012; 18. https://doi.org/10.1111/j.1365-2516.2011.02730.x.

49. KADIR R, CHI C, BOLTON-MAGGS P. Pregnancy and rare bleeding disorders. Haemophilia 2009; 15: 990 - 1005. https://doi.org/10.1111/j.1365-2516.2009.01984.x.

50. Baumann Kreuziger LM, Morton CT, Reding MT. Is prophylaxis required for delivery in women with factor VII deficiency? Haemophilia 2013; 19: 827 - 32. https://doi.org/10.1111/hae.12167.

51. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006; 12: 413 - 6. https://doi.org/10.1111/j.1365-2516.2006.01287.x.

52. Beksac MS, Atak Z, Ozlu T. Severe factor X deficiency in a twin pregnancy. Arch Gynecol Obstet 2010; 281: 151 - 2. https://doi.org/10.1007/s00404-009-1090-4.